These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7038029)

  • 21. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial.
    Roos A; Linn-Rasker SP; van Domburg RT; Tijssen JP; Berghout A
    Arch Intern Med; 2005 Aug 8-22; 165(15):1714-20. PubMed ID: 16087818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levothyroxine dosage and the limitations of current bioequivalence standards.
    Hennessey JV
    Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):474-5. PubMed ID: 16957756
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypothyroidism: detecting and treating early symptoms as the body's energy rheostat is slowly turned down.
    Haddow JE
    J Med Screen; 2010; 17(4):163. PubMed ID: 21258124
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interchangeability of levothyroxine preparations.
    Ridgway EC
    Am J Med; 1996 Feb; 100(2):245-6; author reply 246-7. PubMed ID: 8629666
    [No Abstract]   [Full Text] [Related]  

  • 26. Interchangeability of levothyroxine preparations.
    Davies TF
    Am J Med; 1996 Feb; 100(2):245; author reply 246-7. PubMed ID: 8629665
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of refractory hypothyroidism requiring daily intravenous thyroxine.
    Nagaoka T; Miyakoshi H; Takamura T; Nagai Y; Matsushita S; Kaneko S; Kobayashi K
    J Int Med Res; 2002; 30(4):463-5. PubMed ID: 12235934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioequivalence of generic preparations of levothyroxine.
    Toft A
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):603; author reply 603-4. PubMed ID: 19508682
    [No Abstract]   [Full Text] [Related]  

  • 29. Potency of brand name and generic levothyroxine.
    Stoffer SS; Szpunar WE
    JAMA; 1980 Oct; 244(15):1704-5. PubMed ID: 7411829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomalabsorption of levothyroxine: a case report.
    Ogawa D; Otsuka F; Mimura U; Ueno A; Hashimoto H; Kishida M; Ogura T; Makino H
    Endocr J; 2000 Feb; 47(1):45-50. PubMed ID: 10811292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy?
    Chopra IJ; Baber K
    Metabolism; 2003 Jan; 52(1):122-8. PubMed ID: 12524672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interchangeability of levothyroxine preparations.
    DeGroot LJ
    Am J Med; 1996 Feb; 100(2):244-5; author reply 246-7. PubMed ID: 8629664
    [No Abstract]   [Full Text] [Related]  

  • 33. Overview of thyroidology--1984.
    Channick BJ
    Clin Ther; 1984; 7(1):2-4. PubMed ID: 6549152
    [No Abstract]   [Full Text] [Related]  

  • 34. Levothyroxine bioequivalence.
    Katz MD; Scherger JE
    J Fam Pract; 1998 Feb; 46(2):108-9. PubMed ID: 9487307
    [No Abstract]   [Full Text] [Related]  

  • 35. A new method for the determination of the bioavailability of thyroid hormone preparations.
    Trantow T; Herzog R; Gegenheimer L; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):133-40. PubMed ID: 8007742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo comparison of levothyroxine preparations.
    Ramos-Gabatin A; Jacobson JM; Young RL
    JAMA; 1982 Jan; 247(2):203-5. PubMed ID: 7053460
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
    Saravanan P; Siddique H; Simmons DJ; Greenwood R; Dayan CM
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):261-7. PubMed ID: 17479444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hypothyroidism with L-thyroxine].
    Zgliczyńska-Widłak J
    Pol Tyg Lek; 1993 Jul 5-12; 48(27-28):605-8. PubMed ID: 8090652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral thyroxine: variation in biologic action and tablet content.
    Sawin CT; Surks MI; London M; Ranganathan C; Larsen PR
    Ann Intern Med; 1984 May; 100(5):641-5. PubMed ID: 6546843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.